Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025

Global Artificial Intelligence AI In Respiratory Diseases Market Report 2024

Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025 – By Imaging Type (Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)), By Indication (Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection), By End Use (Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Artificial Intelligence (AI) In Respiratory Diseases Global Market Report 2025

Proud Members Of

Artificial Intelligence (AI) In Respiratory Diseases Market Definition

Artificial intelligence (AI) in respiratory diseases refers to the use of AI and machine learning techniques to aid clinicians in the diagnosis, management, and treatment of various respiratory conditions. It has numerous potential applications in pulmonary medicine, including image analysis, predictive modeling, and disease management.

The main imaging types of artificial intelligence (AI) in respiratory diseases are Magnetic Resonance Imaging (MRI), computed tomography (CT) scan, and electronic patient-reported outcomes (ePRO). AI in chronic obstructive pulmonary disease refers to the application of artificial intelligence (AI) technologies in the diagnosis, management, and treatment of COPD. It is used for the treatment of various indications such as chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary infection, by several end-users, including hospital, diagnostic centers, ambulatory surgical centers, and others.

Artificial Intelligence (AI) In Respiratory Diseases Market Segmentation

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –

1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)

2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection

3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging

2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT

3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments

Artificial Intelligence (AI) In Respiratory Diseases Market Size and growth rate 2025 to 2029: Graph

Artificial Intelligence (AI) In Respiratory Diseases Market Size 2025 And Growth Rate

The artificial intelligence (AI) in respiratory diseases market size has grown strongly in recent years. It will grow from $7.66 billion in 2024 to $8.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing government regulations, growing environmental concerns, increasing aging population, growing patient-centric healthcare approaches, rise in healthcare infrastructure development.

Artificial Intelligence (AI) In Respiratory Diseases Market Growth Forecast

The artificial intelligence (AI) in respiratory diseases market size is expected to see strong growth in the next few years. It will grow to $9.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring.

Book your 30 minutes free consultation with our research experts

Artificial Intelligence (AI) In Respiratory Diseases Market Driver: AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution

Growing environmental pollution is expected to propel the growth of artificial intelligence (AI) in the respiratory disease market going forward. Environmental pollution refers to the addition of any substance or form of energy to the environment at a rate faster than IT can be dispersed or stored in a harmless form. AI in respiratory diseases has the potential to significantly reduce the impact of environmental pollution on respiratory health by offering real-time monitoring, personalized risk assessments, informed decision-making, and innovative solutions for both individuals and communities. For instance, in June 2024, according to the US Energy Information Administration, a US-based government agency, the CO2 emission in 2021 accounted for 35.72 billion metric tons which increased to 38.50 billion metric tons in 2022. Therefore, growing environmental pollution is driving the growth of artificial intelligence (AI) in the respiratory disease market.

Global Artificial Intelligence (AI) In Respiratory Diseases Market Major Players

Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.

Global Artificial Intelligence (AI) In Respiratory Diseases Market Trend: TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management

Major companies operating in artificial intelligence (AI) in the respiratory diseases market are developing innovative products such as N-Tidal devices to monitor patients' tidal breathing. The n-Tidal device measures the volume of air exchanged during normal breathing and provides valuable information about lung function. For instance, in August 2023, TidalSense, a UK-based respiratory technology company, launched N-Tidal, a regulated AI technology for chronic obstructive pulmonary disease (COPD) diagnosis and management. The technology combines N-Tidal's CO2 sensor data with an artificial intelligence platform to measure changes in lung function, aiming to improve the diagnosis and management of this respiratory condition. Clinical studies have demonstrated the technology's high accuracy, and IT is expected to reform the diagnostic process for respiratory diseases. The launch is a significant development in the use of AI for respiratory disease assessment, offering a more comfortable and efficient alternative to existing diagnostic tests.

Artificial Intelligence (AI) In Respiratory Diseases Market Merger And Acquisition: Resmed Inc. Expands Sleep And Respiratory Care Portfolio With Acquisition Of Somnoware

In July 2023, ResMed Inc., a US-based medical equipment company that provides cloud-connectable medical devices, acquired Somnoware for an undisclosed amount. This acquisition strengthens ResMed's sleep and respiratory care portfolio and complements its existing digital respiratory healthcare tools. The acquisition is expected to enhance the management of patient data, ordering of treatment equipment, scheduling appointments, and tracking compliance, ultimately improving patient experience and health outcomes. Somnoware is a US-based cloud-based platform for enhanced respiratory care management and hospital-at-home care.

Regional Outlook For The Global Artificial Intelligence (AI) In Respiratory Diseases Market

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial intelligence (AI) in respiratory diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Artificial Intelligence (AI) In Respiratory Diseases Market?

The artificial Intelligence (AI) in respiratory diseases market includes revenues earned by entities by providing services such as AI-assisted imaging analysis, digital pathology platforms, and AI-powered rehabilitation programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in respiratory diseases market also includes sales IoT devices, wearables, and smart inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Artificial Intelligence (AI) In Respiratory Diseases Industry?

The artificial intelligence (AI) respiratory disease market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) respiratory disease market statistics, including artificial intelligence (AI) respiratory disease industry global market size, regional shares, competitors with an artificial intelligence (AI) respiratory disease market share, detailed artificial intelligence (AI) respiratory disease market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) respiratory disease industry. This artificial intelligence (AI) respiratory disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Artificial Intelligence (AI) In Respiratory Diseases Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$8.05 billion
Revenue Forecast In 2034	$9.85 billion
Growth Rate	CAGR of 5.2% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO) 2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection 3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging 2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT 3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Artificial Intelligence (AI) In Respiratory Diseases Market Characteristics

3. Artificial Intelligence (AI) In Respiratory Diseases Market Trends And Strategies

4. Artificial Intelligence (AI) In Respiratory Diseases Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Intelligence (AI) In Respiratory Diseases Growth Analysis And Strategic Analysis Framework

5.1. Global Artificial Intelligence (AI) In Respiratory Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Artificial Intelligence (AI) In Respiratory Diseases Market Growth Rate Analysis

5.4. Global Artificial Intelligence (AI) In Respiratory Diseases Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Artificial Intelligence (AI) In Respiratory Diseases Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Artificial Intelligence (AI) In Respiratory Diseases Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In Respiratory Diseases Market Segmentation

6.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Magnetic Resonance Imaging (MRI)

Computed Tomography (CT) Scan

Electronic Patient-Reported Outcomes (ePRO)

6.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Obstructive Pulmonary Disease

Interstitial Lung Disease

Pulmonary Infection

6.3. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Diagnostic Centers

Ambulatory Surgical Centers

Other End-Users

6.4. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Imaging

Thoracic Imaging

Cardiopulmonary Imaging

6.5. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High-Resolution CT (HRCT)

Low-Dose CT

Thoracic CT

6.6. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Symptom Tracking

Medication Adherence Monitoring

Quality Of Life Assessments

7. Artificial Intelligence (AI) In Respiratory Diseases Market Regional And Country Analysis

7.1. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market

8.1. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In Respiratory Diseases Market

9.1. China Artificial Intelligence (AI) In Respiratory Diseases Market Overview

9.2. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In Respiratory Diseases Market

10.1. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In Respiratory Diseases Market

11.1. Japan Artificial Intelligence (AI) In Respiratory Diseases Market Overview

11.2. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In Respiratory Diseases Market

12.1. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market

13.1. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market

14.1. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market Overview

14.2. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market

15.1. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market Overview

15.2. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In Respiratory Diseases Market

16.1. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In Respiratory Diseases Market

17.1. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In Respiratory Diseases Market

18.1. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In Respiratory Diseases Market

19.1. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In Respiratory Diseases Market

20.1. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market

21.1. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market Overview

21.2. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In Respiratory Diseases Market

22.1. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In Respiratory Diseases Market

23.1. North America Artificial Intelligence (AI) In Respiratory Diseases Market Overview

23.2. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In Respiratory Diseases Market

24.1. USA Artificial Intelligence (AI) In Respiratory Diseases Market Overview

24.2. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In Respiratory Diseases Market

25.1. Canada Artificial Intelligence (AI) In Respiratory Diseases Market Overview

25.2. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In Respiratory Diseases Market

26.1. South America Artificial Intelligence (AI) In Respiratory Diseases Market Overview

26.2. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market

27.1. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market

28.1. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market Overview

28.2. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In Respiratory Diseases Market

29.1. Africa Artificial Intelligence (AI) In Respiratory Diseases Market Overview

29.2. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape And Company Profiles

30.1. Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape

30.2. Artificial Intelligence (AI) In Respiratory Diseases Market Company Profiles

30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

30.2.3. General Electric (GE) Healthcare Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Verily Life Sciences LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.5. DeepMind Health Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In Respiratory Diseases Market Other Major And Innovative Companies

31.1. Merative L.P.

31.2. Innovaccer

31.3. Freenome

31.4. Aidoc Medical

31.5. Butterfly Network

31.6. Infervision

31.7. Imagen Technologies

31.8. Caption Health

31.9. Gauss Surgical Inc.

31.10. Swaasa AI

31.11. Inspirata Inc.

31.12. VIDA Diagnostics Inc.

31.13. Enlitic

31.14. Thirona B.v.

31.15. ArtiQ

32. Global Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Respiratory Diseases Market

34. Recent Developments In The Artificial Intelligence (AI) In Respiratory Diseases Market

35. Artificial Intelligence (AI) In Respiratory Diseases Market High Potential Countries, Segments and Strategies

35.1 Artificial Intelligence (AI) In Respiratory Diseases Market In 2029 - Countries Offering Most New Opportunities

35.2 Artificial Intelligence (AI) In Respiratory Diseases Market In 2029 - Segments Offering Most New Opportunities

35.3 Artificial Intelligence (AI) In Respiratory Diseases Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Siemens Healthineers Financial Performance

Table 78: Philips Healthcare Financial Performance

Table 79: General Electric (GE) Healthcare Financial Performance

Table 80: Verily Life Sciences LLC Financial Performance

Table 81: DeepMind Health Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Sub-Segmentation Of Electronic Patient-Reported Outcomes (ePRO), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Artificial Intelligence (AI) In Respiratory Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Imaging Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Artificial Intelligence (AI) In Respiratory Diseases Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Siemens Healthineers Financial Performance

Figure 78: Philips Healthcare Financial Performance

Figure 79: General Electric (GE) Healthcare Financial Performance

Figure 80: Verily Life Sciences LLC Financial Performance

Figure 81: DeepMind Health Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Artificial Intelligence Of Things (AIoT) Global Market Report 2025 – By Offering (Solutions, Services), By Deployment (On-Premises, Cloud), By Vertical (Banking, Financial Services and Insurance (BFSI), Manufacturing, Healthcare, Energy And Utilities, Retail, Transportation And Logistics, Other Verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence In Cancer Diagnostics Global Market Report 2025 – By Component (Software Solutions, Hardware, Services), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types), By Application (Screening And Diagnosis, Tumor Identification, Surveillance, Treatment), By End-User (Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence (AI) Engineering Global Market Report 2025 – By Solution (Hardware, Software, Services), By Technology (Deep Learning, Machine Learning, Natural Language Processing, Computer Vision), By Deployment (On-Cloud, On-Premise), By End-User (Healthcare, Automotive And Transportation, Agriculture, Information Technology (IT), Business Management, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence In Magnetic Resonance Imaging (MRI) Global Market Report 2025 – By Offering (Hardware, Software, Services), By Technology (Deep Learning, Machine Learning, Computer Vision, NLP (Natural Language Processing), Speech Recognition, Querying Method, Other Technologies), By Deployment Type (On-Premise, Cloud), By Clinical Applications (Musculoskeletal, Colon, Prostate, Liver, Cardiovascular, Neurology, Lung, Breast, Other Clinical Applications), By End-User (Clinics, Research And Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Enterprise Artificial Intelligence Global Market Report 2025 – By Component (Solution, Service), By Technology (Machine Learning, Natural Language Processing (NLP), Image Processing, Speech Recognition), By Deployment Type (Cloud, On-Premise), By Application (Security And Risk Management, Marketing Management, Customer Support And Experience, Human Resource And Recruitment Management, Analytics Application, Process Automation), By Industry (Retail, Healthcare, Automotive, Banking And Financial Services, Media And Entertainment, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence (AI) Camera Global Market Report 2025 – By Type (Smartphone Camera, Surveillance Camera, DSLR Camera, Other Types), By Technology (Image or Face Recognition, Voice or Speech Recognition, Computer Vision, Other Technologies), By End User (Banking, Financial Services and Insurance (BFSI), Healthcare, Automotive, Retail, Government, Logistics and Transportation, Military and Defense, Commercial Spaces, Media and Entertainment, Other End-Users ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence (AI) in Operating Room Global Market Report 2025 – By Offerings (Hardware, Software-As-A-Service (SaaS)), By Indication (Cardiology, Orthopedics, Urology, Gastroenterology, Neurology, Other Indications), By Technology (Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Computer Vision), By Application (Training And Supporting, Diagnosis And Monitoring, Outcome And Risk Analysis, Surgical Planning And Rehabilitation, Integration And Connectivity, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Standalone Or Specialized Facilities, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Artificial Intelligence Services Global Market Report 2025 – By Technology (Machine Learning, Computer Vision, Natural Language Processing (NLP), Other Technology), By Services Type (Managed Services, Professional Services), By Software Tools (Web-based and Cloud Application Programming Interface, Processing and Modeler, Archiving and Data Storage), By Application Type (Fraud Detection, Data Analytics & Visualization, Customer Service and Management, Risk Management, Compliance & Security), By End-User (Banking, Financial, and Insurance (BFSI), IT & Telecom, Retail, Manufacturing, Public Sector, Energy & Utility, Healthcare, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Artificial Intelligence (AI) In Respiratory Diseases market?

How will the Artificial Intelligence (AI) In Respiratory Diseases market drivers and restraints affect the market dynamics? What forces will shape the Artificial Intelligence (AI) In Respiratory Diseases industry going forward?

The Artificial Intelligence (AI) In Respiratory Diseases market major growth driver - AI Revolutionizing Respiratory Health Addressing The Impact Of Growing Environmental Pollution. For further insights on the Artificial Intelligence (AI) In Respiratory D request a sample here

What is the forecast market size or the forecast market value of the Artificial Intelligence (AI) In Respiratory Diseases market?

The Artificial Intelligence (AI) In Respiratory Diseases market size has grown strongly in recent years. The artificial intelligence (AI) in respiratory diseases market size has grown strongly in recent years. It will grow from $7.66 billion in 2024 to $8.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to increasing government regulations, growing environmental concerns, increasing aging population, growing patient-centric healthcare approaches, rise in healthcare infrastructure development. The artificial intelligence (AI) in respiratory diseases market size is expected to see strong growth in the next few years. It will grow to $9.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing prevalence of respiratory diseases, rising need for early detection and diagnosis, growing environmental pollution, rising healthcare expenditure, research and development initiatives. Major trends in the forecast period include technological advancements, drug discovery and development, personalized treatment plans, telemedicine and remote patient monitoring, remote patient monitoring. For further insights on the Artificial Intelligence (AI) In Respiratory Diseases market, request a sample here

How is the Artificial Intelligence (AI) In Respiratory Diseases market segmented?

The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments For further insights on the Artificial Intelligence (AI) In Respiratory Diseases market, request a sample here

Which region has the largest share of the Artificial Intelligence (AI) In Respiratory Diseases market? What are the other regions covered in the report?

North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Artificial Intelligence (AI) In Respiratory Diseases market, request a sample here.

Who are the major players in the Artificial Intelligence (AI) In Respiratory Diseases market?

What are the key trends in the Artificial Intelligence (AI) In Respiratory Diseases market?

Major trends in the Artificial Intelligence (AI) In Respiratory Diseases market include TidalSense Launches N-Tidal Device For AI-Driven Respiratory Disease Management. For further insights on the Artificial Intelligence (AI) In Respiratory Diseases marke request a sample here.

What are the major opportunities in the Artificial Intelligence (AI) In Respiratory Diseases market? What are the strategies for the Artificial Intelligence (AI) In Respiratory Diseases market?

For detailed insights on the major opportunities and strategies in the Artificial Intelligence (AI) In Respiratory Diseases market, request a sample here.

How does the Artificial Intelligence (AI) In Respiratory Diseases market relate to the overall economy and other similar markets?

For detailed insights on Artificial Intelligence (AI) In Respiratory Diseases's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Artificial Intelligence (AI) In Respiratory Diseases industry?

For detailed insights on the mergers and acquisitions in the Artificial Intelligence (AI) In Respiratory Diseases industry, request a sample here.

What are the key dynamics influencing the Artificial Intelligence (AI) In Respiratory Diseases market growth? SWOT analysis of the Artificial Intelligence (AI) In Respiratory Diseases market.

For detailed insights on the key dynamics influencing the Artificial Intelligence (AI) In Respiratory Diseases market growth and SWOT analysis of the Artificial Intelligence (AI) In Respiratory Diseases industry, request a sample here.